Tag: DoD
-
Institutions Join Global Health Breakthrough Network
Wellcome Leap aims to establish a model for faster design and development of health breakthroughs, beginning with elimination of administrative obstacles.
-
Device-Aided Covid-19 Vaccine Invokes Immune Response
Results from an early clinical trial show a Covid-19 vaccine using an electronic device to boost uptake in cells is safe and generates an immune-system response.
-
Daily Covid-19 Nasal Spray Vaccine in Works
A group of university and government labs is formulating an antiviral drug as a nasal spray for use as a daily preventive vaccine against Covid-19 infections.
-
DoD Funding Mobile Vaccine/Therapy Manufacturing Lab
The U.S. Defense Department’s research agency is funding a prototype mobile lab to produce RNA-based vaccines and therapies in the field on demand.
-
Group Advancing Electronic Spinal Cord Injury Therapies
A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries.
-
DoD Funds Covid-19 G.I. Infection Therapy
A biotechnology company is developing biologic treatments for Covid-19 infections in the gastrointestinal tract and to block further disease transmission.
-
DoD Funding Variable Covid-19 Vaccine Technology
The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus.
-
Biotech Gains Antibody Discovery, Manufacturing Funds
A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics.
-
Covid-19 Antibody Therapy Prepares for Trial
A biotechnology company producing synthetic antibodies in cattle, without human blood, to treat Covid-19 infections is advancing the therapy toward a clinical trial.
-
Small Biz Grant Funds PTSD Diagnostic, Treatment
A company creating diagnostics and a treatment for post-traumatic stress disorder, or PTSD, is receiving initial funding to develop its products.